328 related articles for article (PubMed ID: 16081961)
21. Accumulation of defective neuraminidase (NA) genes by influenza A viruses in the presence of NA inhibitors as a marker of reduced dependence on NA.
Nedyalkova MS; Hayden FG; Webster RG; Gubareva LV
J Infect Dis; 2002 Mar; 185(5):591-8. PubMed ID: 11865415
[TBL] [Abstract][Full Text] [Related]
22. Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells.
Govorkova EA; Fang HB; Tan M; Webster RG
Antimicrob Agents Chemother; 2004 Dec; 48(12):4855-63. PubMed ID: 15561867
[TBL] [Abstract][Full Text] [Related]
23. Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication.
Suzuki T; Takahashi T; Guo CT; Hidari KI; Miyamoto D; Goto H; Kawaoka Y; Suzuki Y
J Virol; 2005 Sep; 79(18):11705-15. PubMed ID: 16140748
[TBL] [Abstract][Full Text] [Related]
24. Mixed influenza A and B infections complicate the detection of influenza viruses with altered sensitivities to neuraminidase inhibitors.
Mohr PG; Geyer H; McKimm-Breschkin JL
Antiviral Res; 2011 Jul; 91(1):20-2. PubMed ID: 21549758
[TBL] [Abstract][Full Text] [Related]
25. A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir.
Matsuzaki Y; Mizuta K; Aoki Y; Suto A; Abiko C; Sanjoh K; Sugawara K; Takashita E; Itagaki T; Katsushima Y; Ujike M; Obuchi M; Odagiri T; Tashiro M
Virol J; 2010 Mar; 7():53. PubMed ID: 20202225
[TBL] [Abstract][Full Text] [Related]
26. Neuraminidase inhibitors as antiviral agents.
Alymova IV; Taylor G; Portner A
Curr Drug Targets Infect Disord; 2005 Dec; 5(4):401-9. PubMed ID: 16535861
[TBL] [Abstract][Full Text] [Related]
27. Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States.
Nguyen HT; Trujillo AA; Sheu TG; Levine M; Mishin VP; Shaw M; Ades EW; Klimov AI; Fry AM; Gubareva LV
Antiviral Res; 2012 Mar; 93(3):381-6. PubMed ID: 22330888
[TBL] [Abstract][Full Text] [Related]
28. Characterization of human H1N1 influenza virus variants selected in vitro with zanamivir in the presence of sialic acid-containing molecules.
Giannecchini S; Campitelli L; Bandini G; Donatelli I; Azzi A
Virus Res; 2007 Nov; 129(2):241-5. PubMed ID: 17765996
[TBL] [Abstract][Full Text] [Related]
29. Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells.
Zhirnov OP; Vorobjeva IV; Saphonova OA; Poyarkov SV; Ovcharenko AV; Anhlan D; Malyshev NA
J Clin Virol; 2009 Aug; 45(4):322-33. PubMed ID: 19546028
[TBL] [Abstract][Full Text] [Related]
30. Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals.
Leang SK; Hurt AC
J Vis Exp; 2017 Apr; (122):. PubMed ID: 28448045
[TBL] [Abstract][Full Text] [Related]
31. Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007.
Tashiro M; McKimm-Breschkin JL; Saito T; Klimov A; Macken C; Zambon M; Hayden FG;
Antivir Ther; 2009; 14(6):751-61. PubMed ID: 19812437
[TBL] [Abstract][Full Text] [Related]
32. In vitro evaluation of the antiviral activity of methylglyoxal against influenza B virus infection.
Charyasriwong S; Haruyama T; Kobayashi N
Drug Discov Ther; 2016; 10(4):201-10. PubMed ID: 27558282
[TBL] [Abstract][Full Text] [Related]
33. Antiviral activity of ethanol extract of Geranii Herba and its components against influenza viruses via neuraminidase inhibition.
Choi JG; Kim YS; Kim JH; Chung HS
Sci Rep; 2019 Aug; 9(1):12132. PubMed ID: 31431635
[TBL] [Abstract][Full Text] [Related]
34. High efficiency method of detection and isolation of neuraminidase inhibitor resistant influenza viruses by fluorescence sialidase imaging.
Kurebayashi Y
Jpn J Antibiot; 2016 Dec; 69(6):357-366. PubMed ID: 30226930
[TBL] [Abstract][Full Text] [Related]
35. Neuraminidase inhibitors as anti-influenza virus agents.
Kim CU; Chen X; Mendel DB
Antivir Chem Chemother; 1999 Jul; 10(4):141-54. PubMed ID: 10480735
[TBL] [Abstract][Full Text] [Related]
36. Toll-like receptor 9 ligand D-type oligodeoxynucleotide D35 as a broad inhibitor for influenza A virus replication that is associated with suppression of neuraminidase activity.
Yamada H; Nagase S; Takahashi K; Sakoda Y; Kida H; Okamoto S
Antiviral Res; 2016 May; 129():81-92. PubMed ID: 26923882
[TBL] [Abstract][Full Text] [Related]
37. Deletions of neuraminidase and resistance to oseltamivir may be a consequence of restricted receptor specificity in recent H3N2 influenza viruses.
Gulati S; Smith DF; Air GM
Virol J; 2009 Feb; 6():22. PubMed ID: 19216793
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network.
Wetherall NT; Trivedi T; Zeller J; Hodges-Savola C; McKimm-Breschkin JL; Zambon M; Hayden FG
J Clin Microbiol; 2003 Feb; 41(2):742-50. PubMed ID: 12574276
[TBL] [Abstract][Full Text] [Related]
39. Tamiphosphor monoesters as effective anti-influenza agents.
Chen CL; Lin TC; Wang SY; Shie JJ; Tsai KC; Cheng YS; Jan JT; Lin CJ; Fang JM; Wong CH
Eur J Med Chem; 2014 Jun; 81():106-18. PubMed ID: 24836064
[TBL] [Abstract][Full Text] [Related]
40. Umifenovir susceptibility monitoring and characterization of influenza viruses isolated during ARBITR clinical study.
Leneva IA; Falynskova IN; Makhmudova NR; Poromov AA; Yatsyshina SB; Maleev VV
J Med Virol; 2019 Apr; 91(4):588-597. PubMed ID: 30431664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
